ARTV
ARTV
Positions held
Your positionsARTV isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-17 · Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
2026-09-09 · Artiva Biotherapeutics Insider Sold Shares Worth $255,746, According to a Recent SEC Filing
2026-09-02 · Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
2026-08-06 · Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-07-17 · Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Price (daily)
Full chart · RSI · MACD · patterns